首页> 外文OA文献 >DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial

【2h】

DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial

机译：带电穿孔的DNA疫苗VGX-3100诱导宫颈上皮内瘤变2/3消退，并通过强烈的T细胞反应清除HPV感染：一项随机，双盲，安慰剂对照的II期临床试验的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Laurent Humeau; Cornelia Trimble; Matthew Morrow; Xuefei Shen; Michael Dallas; David Weiner; Jean Boyer; Jian Yan; Kimberly Kraynyak; Albert Sylvester; Mary Giffear; Kathy Marcozzi-Pierce; Divya Shah; Kate Broderick; Amir Khan; Jessica Lee; Niranjan Sardesai; Mark Bargarazzi; null null;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial [J] . Laurent Humeau, Cornelia Trimble, Matthew Morrow, Journal for ImmunoTherapy of Cancer . 2014,第S3期

机译：带电穿孔的DNA疫苗VGX-3100诱导宫颈上皮内瘤变2/3消退，并通过强烈的T细胞反应清除HPV感染：一项随机，双盲，安慰剂对照的II期临床试验的结果
2. DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial [J] . Laurent Humeau, Cornelia Trimble, Matthew Morrow, Journal for ImmunoTherapy of Cancer . 2014,第S3期

机译：带电穿孔的DNA疫苗VGX-3100诱导宫颈上皮内瘤变2/3消退，并通过强烈的T细胞反应清除HPV感染：一项随机，双盲，安慰剂对照的II期临床试验的结果
3. HPV Specific Immunotherapy for Cervical Intraepithelial Neoplasia using VGX-3100 Induces Regression of Cervical Lesions and Potent T-cell Responses: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study [J] . Morrow Matthew, Trimble Cornelia, Shen Xuefei, Journal of women’s health . 2015,第4期

机译：使用VGX-3100进行宫颈上皮内瘤变的HPV特异性免疫疗法可诱导宫颈病变的消退和强效T细胞反应：一项随机，双盲，安慰剂对照的II期研究的结果
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized double-blind placebo-controlled Phase II trial [O] . Laurent Humeau, Cornelia Trimble, Matthew Morrow, 2014

机译：带电穿孔的DNA疫苗VGX-3100诱导宫颈上皮内瘤变2/3消退并通过强烈的T细胞反应清除HPV感染：一项随机双盲安慰剂对照的II期临床试验的结果
7. Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia [O] . Francisco A.R. Garcia, Terri Cornelison, Tomas Nuño, 2014

机译：具有持续高风险HPV感染和低级宫颈上皮内瘤形成的妇女中的II期随机，双盲，安慰剂对照试验的II期随机，双盲，安慰剂对照试验

DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial

著录项

引文网络

相似文献

相关主题

期刊订阅